Graf Akcie IRMD (Iradimed Corp). Diskuze k akciím IRMD. Aktuální informace IRMD.

Základní informace o společnosti Iradimed Corp (Akcie IRMD)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 427.8M
Hodnota podniku (EV) N/A
Tržby 35.28M
EBITDA N/A
Zisk 4.569M
Růst v tržbách Q/Q 44.38 %
Růst v tržbách Y/Y -2.88 %
P/E (Cena vůči ziskům) 99.11
Forward P/E 12.65
EV/Sales 11.04
EV/EBITDA N/A
EV/EBIT 231.05
PEG 1.64
Price/Sales 12.13
P/FCF 54.92
Price/Book 6.97
Účetní hodnota na akcii 5.26
Hotovost na akcii 4.46
FCF vůči ceně 1.82 %
Počet zaměstnanců 110
Tržba na zaměstnance 320.723k
Profit margin 4.32 %
Operating margin 14.33 %
Gross margin 74.33 %
EBIT margin 14.42 %
EBITDA margin 27.12 %
EPS - Zisk na akcii 0.37
EPS - Kvartální růst 180.00 %
EPS - Očekávaný růst příští rok 54.55 %
Return on assets 6.32 %
Return on equity 7.31 %
ROIC -0.90 %
ROCE 7.34 %
Dluhy/Equity 0.16
Čistý dluh/EBITDA -19.47
Current ratio 10.90
Quick Ratio 10.19
Volatilita 3.62
Beta 0.33
RSI 63.37
Cílová cena analytiků 28
Známka akcie (dle analytiků) N/A
Insider ownership 48.92 %
Institutional ownership 39.79 %
Počet akcií 12.318M
Procento shortovaných akcií 1.92 %
Short ratio 1.62 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 2014
Země United States

Finanční výsledky akcie IRMD

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$38.517$30.439$23.082$32.497$31.594$15.653$11.34$7.685
Cost Of Goods Sold$8.816$7.212$5.57$6.155$5.84$3.404$2.853$2.126
Gross Profit$29.701$23.227$17.512$26.342$25.753$12.249$8.487$5.559
Research And Development Expenses$1.433$1.517$1.723$1.348$1.764$1.069$1.01$0.654
SG&A Expenses$19.621$15.707$14.504$14.074$12.476$8.114$4.69$3.48
Other Operating Income Or Expenses--------
Operating Expenses$29.87$24.435$21.797$21.577$20.081$12.587$8.553$6.26
Operating Income$8.647$6.004$1.285$10.92$11.513$3.066$2.787$1.425
Total Non-Operating Income/Expense$0.396$0.194$0.111$0.033$0.121$-0.049$-0.004$0.007
Pre-Tax Income$9.043$6.197$1.396$10.953$11.635$3.017$2.784$1.432
Income Taxes$-0.588$-0.106$0.897$3.738$4.105$0.967$0.847$0.466
Income After Taxes$9.631$6.304$0.5$7.215$7.53$2.05$1.937$0.966
Other Income--------
Income From Continuous Operations$9.631$6.304$0.5$7.215$7.53$2.05$1.937$0.966
Income From Discontinued Operations--------
Net Income$9.631$6.304$0.5$7.215$7.53$2.05$1.937$0.966
EBITDA$9.89$7.109$2.594$11.876$12.32$3.215$2.926$1.531
EBIT$8.647$6.004$1.285$10.92$11.513$3.066$2.787$1.425
Basic Shares Outstanding1111111111977
Shares Outstanding12121212131098
Basic EPS$0.85$0.59$0.05$0.67$0.68$0.23$0.28$0.14
EPS - Earnings Per Share$0.78$0.52$0.04$0.60$0.60$0.20$0.22$0.11
# 2020 2019 2018 2017 2016 2015
Current Ratio10.06389.49818.60919.245611.75529.7393
Long-term Debt / Capital------
Debt/Equity Ratio------
Gross Margin77.111176.307975.868781.0681.51478.2509
Operating Margin22.450819.7245.567233.603736.441319.5865
EBIT Margin22.450819.7245.567233.603736.441319.5865
EBITDA Margin25.676223.354211.237336.54538.996420.5388
Pre-Tax Profit Margin23.478720.35986.049833.704336.825519.2764
Net Profit Margin25.004320.70852.165222.20123.833613.0988
Asset Turnover0.57720.62840.59160.87370.89640.6715
Inventory Turnover Ratio2.4211.77651.32281.58362.45071.6014
Receiveable Turnover5.28127.23026.1088.60688.17727.9854
Days Sales In Receivables69.113550.482959.75842.408544.636345.7085
ROE - Return On Equity17.345515.02761.517622.623823.58049.8147
Return On Tangible Equity17.618415.33191.559623.29523.72399.934
ROA - Return On Assets14.43313.01231.28119.396821.3658.7962
ROI - Return On Investment17.345515.02761.517622.623823.58049.8147
Book Value Per Share4.71913.81713.10762.97392.85751.9316
Operating Cash Flow Per Share0.22450.3176-0.4930.17530.35620.082
Free Cash Flow Per Share0.21340.3649-0.49410.1340.38950.0439